Life sciences organizations need real-world evidence to validate therapies, optimize clinical trials, and demonstrate value to payers. Yet access to structured, longitudinal, payer-aligned data remains a challenge.
cliexa bridges life sciences with real-world clinical practice. By aggregating EMR, claims, and patient-reported data, cliexa provides predictive insights into patient outcomes, treatment adherence, and payer coverage alignment. With tools like cliexaProspect for risk modeling and cliexaGuidelines for personalized care pathways, life sciences teams gain actionable evidence to support trial design, product adoption, and reimbursement strategies.
At top 10 life science company leveraged our platform to predict kidney function decline with 88% accuracy, identify at-risk patients up to 18 months earlier than conventional methods, boost appropriate chronic kidney disease screening in high-risk groups by 37%, and cut inappropriate nephrology referrals by 83%, accelerating recruitment and improving trial outcomes.
